Correlation Between Poseida Therapeutics and Molecular Partners
Can any of the company-specific risk be diversified away by investing in both Poseida Therapeutics and Molecular Partners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Poseida Therapeutics and Molecular Partners into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Poseida Therapeutics and Molecular Partners AG, you can compare the effects of market volatilities on Poseida Therapeutics and Molecular Partners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Poseida Therapeutics with a short position of Molecular Partners. Check out your portfolio center. Please also check ongoing floating volatility patterns of Poseida Therapeutics and Molecular Partners.
Diversification Opportunities for Poseida Therapeutics and Molecular Partners
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Poseida and Molecular is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Poseida Therapeutics and Molecular Partners AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Molecular Partners and Poseida Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Poseida Therapeutics are associated (or correlated) with Molecular Partners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Molecular Partners has no effect on the direction of Poseida Therapeutics i.e., Poseida Therapeutics and Molecular Partners go up and down completely randomly.
Pair Corralation between Poseida Therapeutics and Molecular Partners
If you would invest 568.00 in Molecular Partners AG on November 28, 2024 and sell it today you would lose (78.00) from holding Molecular Partners AG or give up 13.73% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Poseida Therapeutics vs. Molecular Partners AG
Performance |
| Timeline |
| Poseida Therapeutics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
| Molecular Partners |
Poseida Therapeutics and Molecular Partners Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Poseida Therapeutics and Molecular Partners
The main advantage of trading using opposite Poseida Therapeutics and Molecular Partners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Poseida Therapeutics position performs unexpectedly, Molecular Partners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Molecular Partners will offset losses from the drop in Molecular Partners' long position.| Poseida Therapeutics vs. Molecular Partners AG | Poseida Therapeutics vs. Mineralys Therapeutics, Common | Poseida Therapeutics vs. AN2 Therapeutics | Poseida Therapeutics vs. Pharvaris BV |
| Molecular Partners vs. Mineralys Therapeutics, Common | Molecular Partners vs. AN2 Therapeutics | Molecular Partners vs. Pharvaris BV | Molecular Partners vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |